Spine Stereotactic Radiosurgery Provides Long-Term Local Control and Overall Survival for Benign Intradural Tumors.

IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY
Suchet Taori, Samuel Adida, Michael R Kann, Shovan Bhatia, Roberta K Sefcik, Steven A Burton, John C Flickinger, Pascal O Zinn, Peter C Gerszten
{"title":"Spine Stereotactic Radiosurgery Provides Long-Term Local Control and Overall Survival for Benign Intradural Tumors.","authors":"Suchet Taori, Samuel Adida, Michael R Kann, Shovan Bhatia, Roberta K Sefcik, Steven A Burton, John C Flickinger, Pascal O Zinn, Peter C Gerszten","doi":"10.1227/neu.0000000000003219","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The role of radiosurgery in the treatment of benign intracranial tumors is well established. However, there are limited long-term follow-up studies on outcomes after stereotactic radiosurgery (SRS) for benign intradural spinal tumors. In this article, we report a large single-institution experience in using SRS to treat patients with benign intradural tumors of the spine.</p><p><strong>Methods: </strong>Overall, 184 patients (55% female) and 207 benign intradural tumors were treated. The median patient age was 52 years (range: 19-93). Tumor histology included schwannoma (38%), meningioma (15%), neurofibroma (21%), hemangioma (9%), hemangioblastoma (8%), hemangiopericytoma (5%), and paraganglioma (4%). Thirty-four (16%) lesions underwent resection before radiosurgery. Twenty-three (11%) lesions were NF1-mutated. The median single-fraction margin dose was 14 Gy (range: 11-20), and the median multifraction margin dose was 21 Gy (range: 15-30).</p><p><strong>Results: </strong>The median follow-up was 63 months (range: 1-258). At last follow-up, tumors volumetrically regressed (15%), remained stable (77%), or locally progressed (8%, median: 20 months [range: 3-161]) after SRS. The 1-, 5-, and 10-year local control rates were 97%, 92%, and 90%, respectively. On multivariable analysis, the absence of the NF1 mutation (P = .004, hazard ratio: 0.23, 95% CI: 0.08-0.63) and single-fraction SRS (P = .007, hazard ratio: 0.24, 95% CI: 0.08-0.68) correlated with improved local control. The median overall survival was 251 months (range: 1-258), and 1-, 5-, and 10-year overall survival rates were 95%, 85%, and 70%, respectively. For patients with pre-existing symptoms, tumor-associated pain and neurological deficits were noted to improve or remain stable in 85% and 87% of cases, respectively. Adverse radiation effects included delayed myelopathy (1%), acute pain flare (9%), dermatitis (0.5%), dysphagia (0.5%), and dysphonia (0.5%).</p><p><strong>Conclusion: </strong>With long-term follow-up, spine radiosurgery is a safe and effective treatment for benign intradural tumors. In carefully selected patients, even with an NF1 mutation, SRS is associated with a high likelihood of local tumor control.</p>","PeriodicalId":19276,"journal":{"name":"Neurosurgery","volume":null,"pages":null},"PeriodicalIF":3.9000,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1227/neu.0000000000003219","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: The role of radiosurgery in the treatment of benign intracranial tumors is well established. However, there are limited long-term follow-up studies on outcomes after stereotactic radiosurgery (SRS) for benign intradural spinal tumors. In this article, we report a large single-institution experience in using SRS to treat patients with benign intradural tumors of the spine.

Methods: Overall, 184 patients (55% female) and 207 benign intradural tumors were treated. The median patient age was 52 years (range: 19-93). Tumor histology included schwannoma (38%), meningioma (15%), neurofibroma (21%), hemangioma (9%), hemangioblastoma (8%), hemangiopericytoma (5%), and paraganglioma (4%). Thirty-four (16%) lesions underwent resection before radiosurgery. Twenty-three (11%) lesions were NF1-mutated. The median single-fraction margin dose was 14 Gy (range: 11-20), and the median multifraction margin dose was 21 Gy (range: 15-30).

Results: The median follow-up was 63 months (range: 1-258). At last follow-up, tumors volumetrically regressed (15%), remained stable (77%), or locally progressed (8%, median: 20 months [range: 3-161]) after SRS. The 1-, 5-, and 10-year local control rates were 97%, 92%, and 90%, respectively. On multivariable analysis, the absence of the NF1 mutation (P = .004, hazard ratio: 0.23, 95% CI: 0.08-0.63) and single-fraction SRS (P = .007, hazard ratio: 0.24, 95% CI: 0.08-0.68) correlated with improved local control. The median overall survival was 251 months (range: 1-258), and 1-, 5-, and 10-year overall survival rates were 95%, 85%, and 70%, respectively. For patients with pre-existing symptoms, tumor-associated pain and neurological deficits were noted to improve or remain stable in 85% and 87% of cases, respectively. Adverse radiation effects included delayed myelopathy (1%), acute pain flare (9%), dermatitis (0.5%), dysphagia (0.5%), and dysphonia (0.5%).

Conclusion: With long-term follow-up, spine radiosurgery is a safe and effective treatment for benign intradural tumors. In carefully selected patients, even with an NF1 mutation, SRS is associated with a high likelihood of local tumor control.

脊柱立体定向放射外科为良性硬膜内肿瘤提供长期局部控制和总体生存率
背景和目的:放射手术在治疗颅内良性肿瘤中的作用已得到公认。然而,对脊柱硬膜内良性肿瘤进行立体定向放射外科手术(SRS)治疗后的长期随访研究却很有限。在这篇文章中,我们报告了一个大型单机构使用 SRS 治疗脊柱硬膜内良性肿瘤患者的经验:方法:共治疗了 184 名患者(55% 为女性)和 207 个良性硬膜内肿瘤。患者年龄中位数为 52 岁(19-93 岁)。肿瘤组织学包括分裂瘤(38%)、脑膜瘤(15%)、神经纤维瘤(21%)、血管瘤(9%)、血管母细胞瘤(8%)、血管外细胞瘤(5%)和副神经节瘤(4%)。34个病灶(16%)在放射外科手术前进行了切除。23个病灶(11%)为NF1突变。单分次边缘剂量中位数为14 Gy(范围:11-20),多分次边缘剂量中位数为21 Gy(范围:15-30):中位随访时间为 63 个月(范围:1-258)。在最后一次随访中,SRS术后肿瘤体积消退(15%)、保持稳定(77%)或局部进展(8%,中位:20个月[范围:3-161])。1年、5年和10年的局部控制率分别为97%、92%和90%。在多变量分析中,无 NF1 突变(P = .004,危险比:0.23,95% CI:0.08-0.63)和单剂量 SRS(P = .007,危险比:0.24,95% CI:0.08-0.68)与局部控制率的改善相关。中位总生存期为251个月(范围:1-258),1年、5年和10年总生存率分别为95%、85%和70%。对于已有症状的患者,85%和87%的病例中肿瘤相关疼痛和神经功能缺损得到改善或保持稳定。放射不良反应包括延迟性脊髓病(1%)、急性疼痛发作(9%)、皮炎(0.5%)、吞咽困难(0.5%)和发音障碍(0.5%):结论:经过长期随访,脊柱放射手术是一种安全有效的硬膜内良性肿瘤治疗方法。结论:经过长期随访,脊柱放射手术是治疗硬膜内良性肿瘤的安全有效方法。对于经过严格筛选的患者,即使存在 NF1 基因突变,脊柱放射手术也能很好地控制局部肿瘤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurosurgery
Neurosurgery 医学-临床神经学
CiteScore
8.20
自引率
6.20%
发文量
898
审稿时长
2-4 weeks
期刊介绍: Neurosurgery, the official journal of the Congress of Neurological Surgeons, publishes research on clinical and experimental neurosurgery covering the very latest developments in science, technology, and medicine. For professionals aware of the rapid pace of developments in the field, this journal is nothing short of indispensable as the most complete window on the contemporary field of neurosurgery. Neurosurgery is the fastest-growing journal in the field, with a worldwide reputation for reliable coverage delivered with a fresh and dynamic outlook.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信